2010 Leadership in Pharmaceuticals and Biotechnology Breakfast: Spotlight on Business Development, Licensing and Commercialization
(Morristown)
Thursday, December 2, 2010
Morristown, NJ
Perspectives By:
Anne Altmeyer, PhD, MBA, MPH
Executive Director, Business Development & Licensing, Oncology
Novartis Pharmaceuticals Corporation
Barbara J. Dalton
Vice President, Pfizer Ventures Investments - Worldwide Business Development
Pfizer
Sheila Dell, Ph.D
Vice President, Business Development
Catalent Pharma Solutions
Pamela Demain
Executive Director, Corporate Licensing
Merck & Co., Inc.
Milton H. Grannatt, Ph.D.
Vice President & Head, Negotiations, Respiratory & New Growth Opportunities Global Business Development & Licensing
Novartis Pharmaceuticals Corporation
Richard Hoyt
Vice President Asset and Portfolio Management
Covidien Pharmaceuticals
Rita Kelley
Managing Director, Kelley & Associates
Former Senior Director, Millennium Pharmaceuticals
Kiva Kolstein
Vice President
Gerson Lehrman Group
David Nicholson, PhD
Senior Vice President and Head Worldwide Licensing and Knowledge Management
Merck Research Laboratories
Shannon Pettypiece
Reporter
Bloomberg Television
Sam Rasty, Ph.D., MBA
Director, Corporate Development
Endo Pharmaceuticals, Inc.
Don Urbanowicz
Vice President, Business Development
Stryker Corporation
Summary:
Argyle Executive Forum, in partnership with Gerson Lehrman Group, presents its Leadership in Pharmaceuticals and Biotechnology Breakfast: Spotlight on Business Development, Licensing and Commercialization. This breakfast convenes approximately 30 top business development, licensing and commercialization executives from leading pharmaceutical & biotechnology companies. The breakfast provides ample opportunities for informal conversations and networking, as well as formal panel presentations.
Topics to be discussed may include but are not limited to:
- Investment trends in pharmaceuticals & biotechnology
- Important developments in 2010 and their impact on the industry as a whole
- Alliances and joint ventures as part of your overall business development strategy
- Measuring the success of an alliance
- Maintaining a portfolio of products within a company
- Responding to changes in the market
- Flexibility and risk taking
- Strategic partnering to improve R&D productivity
- A look into the future: What will the pharma/biotech space look like in 5 years? 10 years?
Argyle meetings are by invitation only. If you did not receive an invitation but would like to inquire about attendance, please click here.
*Press policies for member meetings are set at the individual session level. Some sessions may be on the record, while others are off. Please consult the meeting agenda, which will indicate which sessions are off the record. To inquire about media presence, please click here.
A Joint Event With:
|
|
|
Date: Thursday, December 2, 2010
Time: 8:00am – 11:30am
Location: Morristown, NJ
*Event location will be disclosed to attendees upon completion of the registration process.
- Meeting Overview
- Event Partner
- Agenda
- Speaking Faculty
- Participation Requirements
- Travel and Other Information
Advance registration is required for all member meetings. Registration is not available onsite.
To download the program from this member meeting please fill out the form below: